ID   MK15_HUMAN              Reviewed;         544 AA.
AC   Q8TD08; Q2TCF9; Q8N362;
DT   18-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   15-MAR-2017, entry version 133.
DE   RecName: Full=Mitogen-activated protein kinase 15;
DE            Short=MAP kinase 15;
DE            Short=MAPK 15;
DE            EC=2.7.11.24;
DE   AltName: Full=Extracellular signal-regulated kinase 7;
DE            Short=ERK-7;
DE   AltName: Full=Extracellular signal-regulated kinase 8;
DE            Short=ERK-8;
GN   Name=MAPK15; Synonyms=ERK7, ERK8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY,
RP   INTERACTION WITH CSK, MUTAGENESIS OF LYS-42; THR-175 AND TYR-177,
RP   PHOSPHORYLATION AT THR-175 AND TYR-177, CHARACTERIZATION, AND
RP   FUNCTION.
RC   TISSUE=Testis;
RX   PubMed=11875070; DOI=10.1074/jbc.M112483200;
RA   Abe M.K., Saelzler M.P., Espinosa R. III, Kahle K.T., Hershenson M.B.,
RA   Le Beau M.M., Rosner M.R.;
RT   "ERK8, a new member of the mitogen-activated protein kinase family.";
RL   J. Biol. Chem. 277:16733-16743(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, FUNCTION,
RP   AND INTERACTION WITH ABL1 AND RET.
RC   TISSUE=Medulla oblongata;
RX   PubMed=16484222; DOI=10.1074/jbc.M513397200;
RA   Iavarone C., Acunzo M., Carlomagno F., Catania A., Melillo R.M.,
RA   Carlomagno S.M., Santoro M., Chiariello M.;
RT   "Activation of the Erk8 mitogen-activated protein (MAP) kinase by
RT   RET/PTC3, a constitutively active form of the RET proto-oncogene.";
RL   J. Biol. Chem. 281:10567-10576(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INTERACTION WITH TGFB1I1.
RX   PubMed=16624805; DOI=10.1074/jbc.M512418200;
RA   Saelzler M.P., Spackman C.C., Liu Y., Martinez L.C., Harris J.P.,
RA   Abe M.K.;
RT   "ERK8 down-regulates transactivation of the glucocorticoid receptor
RT   through Hic-5.";
RL   J. Biol. Chem. 281:16821-16832(2006).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [6]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-449, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- FUNCTION: In vitro, phosphorylates MBP.
CC       {ECO:0000269|PubMed:11875070, ECO:0000269|PubMed:16484222}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Activated by threonine and tyrosine
CC       phosphorylation. Inhibited by dual specificity phosphatases, such
CC       as DUSP1 (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with CSK/c-Src, ABL1, RET and TGFB1I1.
CC       {ECO:0000269|PubMed:11875070, ECO:0000269|PubMed:16484222,
CC       ECO:0000269|PubMed:16624805}.
CC   -!- INTERACTION:
CC       P24941:CDK2; NbExp=4; IntAct=EBI-1383794, EBI-375096;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8TD08-1; Sequence=Displayed;
CC       Name=2; Synonyms=Erk8 delta;
CC         IsoId=Q8TD08-2; Sequence=VSP_017919, VSP_017920;
CC         Note=Appears not to be a CSK- and RET-dependent activated
CC         kinase.;
CC       Name=3;
CC         IsoId=Q8TD08-3; Sequence=VSP_017918, VSP_017921;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed with a maximal expression in
CC       lung and kidney. {ECO:0000269|PubMed:11875070,
CC       ECO:0000269|PubMed:16484222}.
CC   -!- DOMAIN: The N-terminal region (1-20) is the minimal region
CC       necessary for ubiquitination and further proteasomal degradation.
CC       {ECO:0000250}.
CC   -!- DOMAIN: The TXY motif contains the threonine and tyrosine residues
CC       whose phosphorylation activates the MAP kinases.
CC   -!- PTM: Dually phosphorylated on Thr-175 and Tyr-177, which activates
CC       the enzyme. Autophosphorylated on threonine and tyrosine residues
CC       in vitro. {ECO:0000269|PubMed:11875070}.
CC   -!- PTM: Ubiquitinated. Ubiquitination may allow its tight kinase
CC       activity regulation and rapid turnover. May be ubiquitinated by a
CC       SCF E3 ligase (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. MAP kinase subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY065978; AAL40897.1; -; mRNA.
DR   EMBL; AY994058; AAY44299.1; -; mRNA.
DR   EMBL; BC028034; AAH28034.1; -; mRNA.
DR   CCDS; CCDS6409.2; -. [Q8TD08-1]
DR   RefSeq; NP_620590.2; NM_139021.2. [Q8TD08-1]
DR   UniGene; Hs.493169; -.
DR   ProteinModelPortal; Q8TD08; -.
DR   SMR; Q8TD08; -.
DR   BioGrid; 128827; 21.
DR   IntAct; Q8TD08; 9.
DR   STRING; 9606.ENSP00000337691; -.
DR   BindingDB; Q8TD08; -.
DR   ChEMBL; CHEMBL5198; -.
DR   GuidetoPHARMACOLOGY; 2090; -.
DR   iPTMnet; Q8TD08; -.
DR   PhosphoSitePlus; Q8TD08; -.
DR   BioMuta; MAPK15; -.
DR   DMDM; 74760462; -.
DR   EPD; Q8TD08; -.
DR   MaxQB; Q8TD08; -.
DR   PaxDb; Q8TD08; -.
DR   PeptideAtlas; Q8TD08; -.
DR   PRIDE; Q8TD08; -.
DR   DNASU; 225689; -.
DR   Ensembl; ENST00000338033; ENSP00000337691; ENSG00000181085. [Q8TD08-1]
DR   Ensembl; ENST00000395107; ENSP00000378539; ENSG00000181085. [Q8TD08-3]
DR   Ensembl; ENST00000395108; ENSP00000378540; ENSG00000181085. [Q8TD08-2]
DR   Ensembl; ENST00000615253; ENSP00000483093; ENSG00000274205. [Q8TD08-1]
DR   GeneID; 225689; -.
DR   KEGG; hsa:225689; -.
DR   UCSC; uc003yzj.4; human. [Q8TD08-1]
DR   CTD; 225689; -.
DR   DisGeNET; 225689; -.
DR   GeneCards; MAPK15; -.
DR   HGNC; HGNC:24667; MAPK15.
DR   HPA; HPA002704; -.
DR   neXtProt; NX_Q8TD08; -.
DR   OpenTargets; ENSG00000181085; -.
DR   PharmGKB; PA142671478; -.
DR   eggNOG; KOG0660; Eukaryota.
DR   eggNOG; ENOG410XNY0; LUCA.
DR   GeneTree; ENSGT00550000074298; -.
DR   HOGENOM; HOG000233024; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; Q8TD08; -.
DR   KO; K19603; -.
DR   OMA; IRGDWNR; -.
DR   OrthoDB; EOG091G08QL; -.
DR   PhylomeDB; Q8TD08; -.
DR   TreeFam; TF105101; -.
DR   SignaLink; Q8TD08; -.
DR   SIGNOR; Q8TD08; -.
DR   GeneWiki; MAPK15; -.
DR   GenomeRNAi; 225689; -.
DR   PRO; PR:Q8TD08; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000181085; -.
DR   CleanEx; HS_MAPK15; -.
DR   Genevisible; Q8TD08; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005576; C:extracellular region; NAS:UniProtKB.
DR   GO; GO:0005622; C:intracellular; NAS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004707; F:MAP kinase activity; IDA:UniProtKB.
DR   GO; GO:0017124; F:SH3 domain binding; NAS:UniProtKB.
DR   GO; GO:0051973; P:positive regulation of telomerase activity; IDA:BHF-UCL.
DR   GO; GO:1904355; P:positive regulation of telomere capping; IDA:BHF-UCL.
DR   GO; GO:0032212; P:positive regulation of telomere maintenance via telomerase; IDA:BHF-UCL.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0010468; P:regulation of gene expression; IBA:GO_Central.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR003527; MAP_kinase_CS.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS01351; MAPK; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Kinase;
KW   Methylation; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase;
KW   Ubl conjugation.
FT   CHAIN         1    544       Mitogen-activated protein kinase 15.
FT                                /FTId=PRO_0000232637.
FT   DOMAIN       13    304       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      19     27       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOTIF       175    177       TXY.
FT   ACT_SITE    137    137       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   BINDING      42     42       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     175    175       Phosphothreonine.
FT                                {ECO:0000269|PubMed:11875070}.
FT   MOD_RES     177    177       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:11875070}.
FT   MOD_RES     449    449       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   VAR_SEQ      95     95       M -> MGCPPSPPPPTAVRTLSA (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_017918.
FT   VAR_SEQ     241    254       DLLALGSGCRASVL -> GAQTACRSGTGAST (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:16484222}.
FT                                /FTId=VSP_017919.
FT   VAR_SEQ     255    544       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:16484222}.
FT                                /FTId=VSP_017920.
FT   VAR_SEQ     261    544       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_017921.
FT   VARIANT     221    221       T -> K (in dbSNP:rs60732298).
FT                                /FTId=VAR_061535.
FT   VARIANT     505    505       S -> P (in dbSNP:rs56038219).
FT                                /FTId=VAR_061536.
FT   MUTAGEN      42     42       K->R: Loss of autophosphorylation and
FT                                activity. {ECO:0000269|PubMed:11875070}.
FT   MUTAGEN     175    175       T->A: Loss of autophosphorylation and
FT                                activity. {ECO:0000269|PubMed:11875070}.
FT   MUTAGEN     177    177       Y->A: Loss of autophosphorylation and
FT                                activity. {ECO:0000269|PubMed:11875070}.
FT   CONFLICT    113    113       H -> R (in Ref. 2; AAY44299).
FT                                {ECO:0000305}.
SQ   SEQUENCE   544 AA;  59832 MW;  758E0E3B9654AAC5 CRC64;
     MCTVVDPRIV RRYLLRRQLG QGAYGIVWKA VDRRTGEVVA IKKIFDAFRD KTDAQRTFRE
     ITLLQEFGDH PNIISLLDVI RAENDRDIYL VFEFMDTDLN AVIRKGGLLQ DVHVRSIFYQ
     LLRATRFLHS GHVVHRDQKP SNVLLDANCT VKLCDFGLAR SLGDLPEGPE DQAVTEYVAT
     RWYRAPEVLL SSHRYTLGVD MWSLGCILGE MLRGRPLFPG TSTLHQLELI LETIPPPSEE
     DLLALGSGCR ASVLHQLGSR PRQTLDALLP PDTSPEALDL LRRLLVFAPD KRLSATQALQ
     HPYVQRFHCP SDEWAREADV RPRAHEGVQL SVPEYRSRVY QMILECGGSS GTSREKGPEG
     VSPSQAHLHK PRADPQLPSR TPVQGPRPRP QSSPGHDPAE HESPRAAKNV PRQNSAPLLQ
     TALLGNGERP PGAKEAPPLT LSLVKPSGRG AAPSLTSQAA AQVANQALIR GDWNRGGGVR
     VASVQQVPPR LPPEARPGRR MFSTSALQGA QGGARALLGG YSQAYGTVCH SALGHLPLLE
     GHHV
//
